T
Toshiaki A. Furukawa
Researcher at Nagoya City University
Publications - 96
Citations - 6739
Toshiaki A. Furukawa is an academic researcher from Nagoya City University. The author has contributed to research in topics: Mental health & Depression (differential diagnoses). The author has an hindex of 37, co-authored 96 publications receiving 6299 citations. Previous affiliations of Toshiaki A. Furukawa include Nagoya University.
Papers
More filters
Journal ArticleDOI
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Andrea Cipriani,Andrea Cipriani,Toshiaki A. Furukawa,Georgia Salanti,John R. Geddes,Julian P T Higgins,Rachel Churchill,Norio Watanabe,Atsuo Nakagawa,Ichiro M Omori,Hugh McGuire,Michele Tansella,Corrado Barbui +12 more
TL;DR: Clinically important differences exist between commonly prescribed antidepressants for both efficacy and acceptability in favour of escitalopram and sertraline, which might be the best choice when starting treatment for moderate to severe major depression in adults.
Journal ArticleDOI
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
John R. Geddes,Stuart Carney,C Davies,Toshiaki A. Furukawa,David J. Kupfer,Ellen Frank,Guy M. Goodwin +6 more
TL;DR: Continuing treatment with antidepressants in patients with depressive disorders who have responded to acute treatment reduced the odds of relapse by 70% and seemed to persist for up to 36 months, although most trials were of 12 months' duration, and so the evidence on longer-term treatment requires confirmation.
Journal ArticleDOI
Cross-cultural validation of the Beck Depression Inventory-II in Japan
Masayo Kojima,Toshiaki A. Furukawa,Hidekatsu Takahashi,Makoto Kawai,Teruo Nagaya,Shinkan Tokudome +5 more
TL;DR: The Japanese version of the BDI-II is psychometrically robust and can be used to assess depressive symptoms in Japanese people and is confirmed to have a two-factor structure similar to the original model demonstrated by Beck et al. (1996).
Journal ArticleDOI
Twelve‐month prevalence, severity, and treatment of common mental disorders in communities in Japan: preliminary finding from the World Mental Health Japan Survey 2002–2003
Norito Kawakami,Tadashi Takeshima,Yutaka Ono,Hidenori Uda,Yukihiro Hata,Yoshibumi Nakane,Hideyuki Nakane,Noboru Iwata,Toshiaki A. Furukawa,Takehiko Kikkawa +9 more
TL;DR: The study confirmed that the prevalence of DSM‐IV mental disorders was equal to that observed in Asian countries but higher than that in Western countries and low even for those who suffered severe or moderate disorders.
Journal ArticleDOI
Can we individualize the ‘number needed to treat’? An empirical study of summary effect measures in meta-analyses
TL;DR: The fixed effects OR, random effects OR and random effects RR appear to be reasonably constant across different baseline risks, and clinicians may wish to rely on the random effects model RR and use the PEER to individualize NNT when they apply the results of a meta-analysis in their practice.